TER Teradyne
AI test duopoly delivered; after the selloff, price finally matches value, but it's not a bargain.
The story
Teradyne is one of two global leaders in semiconductor test, and the AI build-out has made its SoC and HBM memory testers essential for GPU, custom ASIC and high-bandwidth memory ramps. TTM revenue of $4.46B (+40% on FY) at a 30% operating margin shows the AI test cycle arriving roughly as my last take expected. Robotics remains a small drag. The business is still cyclical, and the current upswing has to be underwritten as a strong upcycle that will eventually mean-revert, not as a permanent new plateau.
No driver moves. TTM results (+40% revenue, 30.4% margin, 1.49 sales-to-capital) track the prior story, so 28% next-year growth, a 32% duopoly-peak-adjusted margin and 1.6 sales-to-capital still fit. The 36% price drop from $383.85 to $246 is a change in the market's view, not in the fundamentals. It closes the gap to my prior ~$242 value without justifying more optimism.
Value drivers
| Revenue growth (Y1) | 28.0% |
| Terminal growth | 4.0% |
| Forecast horizon | 10y |
| Target operating margin | 32.0% |
| Years to target margin | 3 |
| Sales-to-capital | 1.60 |
| Beta | 1.35 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 10.9% |
| Terminal WACC | 9.3% |
Valuation bridge
| PV of explicit FCFF | 13.70B |
| PV of terminal value | 27.67B |
| Equity value | 40.63B |
| ÷ shares → per share | $260.22 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 5.71B | 28.0% | 31.0% | 1.55B | 781.21M | 772.70M | 696.69M |
| 2 | 7.16B | 25.3% | 31.5% | 1.98B | 904.71M | 1.08B | 874.56M |
| 3 | 8.78B | 22.7% | 32.0% | 2.47B | 1.01B | 1.46B | 1.07B |
| 4 | 10.54B | 20.0% | 32.0% | 2.96B | 1.10B | 1.87B | 1.23B |
| 5 | 12.37B | 17.3% | 32.0% | 3.48B | 1.14B | 2.34B | 1.39B |
| 6 | 14.18B | 14.7% | 32.0% | 3.99B | 1.13B | 2.85B | 1.53B |
| 7 | 15.89B | 12.0% | 32.0% | 4.47B | 1.06B | 3.40B | 1.65B |
| 8 | 17.37B | 9.3% | 32.0% | 4.88B | 926.63M | 3.96B | 1.73B |
| 9 | 18.53B | 6.7% | 32.0% | 5.21B | 723.65M | 4.48B | 1.77B |
| 10 | 19.27B | 4.0% | 32.0% | 5.42B | 463.14M | 4.95B | 1.76B |
Key risks
- Semiconductor test cyclicality: AI capex digestion or customer inventory corrections could cut tester orders 30%+ in a downturn year
- Customer concentration in a few AI accelerator and HBM makers, plus share shifts versus Advantest at key sockets
- Export controls and China exposure, plus continued losses or write-downs in the robotics segment
Catalysts
- HBM4 and next-gen custom ASIC ramps driving SoC and memory test bookings through 2027
- Robotics restructuring or divestiture lifting consolidated margins and focusing capital on test